Applied Biosystems/MDS Analytical Technologies Launches New Mass Spectrometry Tools to Advance Public Health and Safety

CARLSBAD, Calif.--(BUSINESS WIRE)--Applied Biosystems, a division of Life Technologies Corporation (NASDAQ:LIFE), and its mass spectrometry joint-venture partner, MDS Analytical Technologies, a business unit of MDS Inc. (TSX:MDS) (NYSE:MDZ), today announced the commercial availability of new mass spectrometry tools to help laboratories in a variety of industries advance their efforts to improve public health and safety. The Cliquid® 3.0 Software application and mTRAQ® triplex reagents are designed to enhance food and water contaminant testing, forensic drug screening and protein biomarker research.